Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF MARKETING OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,843 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 1,109 · Balance 46,267 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,404 · Balance 47,671 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 3,255 · Balance 50,926 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 2,083 · Balance 48,843 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,658 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 1,109 · Balance 6,658 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,808 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,404 · Balance 2,808 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,532 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 3,255 · Balance 19,532 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,083 | $7.16 | $14,922.61 |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,843 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,532 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,808 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,658 Underlying: Common Stock · 1,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000190 · wk-form4_1725480735.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 07, 2024 Filed Aug 8, 2024 17:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 15,000 | $7.60 | $114,000.00 |
DisclosureSEC source: 0001628280-24-036271 · wk-form4_1723153889.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,158 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 30, 2024. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,096 | $11.16 | $23,385.07 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,158 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,787 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,767 Underlying: Common Stock · 1,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 16:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 46,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000077 · wk-form4_1710965556.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,700 Underlying: Common Stock · 46,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,945 | $14.52 | $115,329.62 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,486 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 14 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F12 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 13,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 13 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,042 Underlying: Common Stock · 13,021 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 12 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,616 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 11 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 10 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F8 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 9 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,876 Underlying: Common Stock · 4,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 13,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · derivative · entry 8 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,313 Underlying: Common Stock · 13,313 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 6 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,021 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 5 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000046 · wk-form4_1709672996.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 16:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 509 | $18.90 | $9,621.12 |
DisclosureSEC source: 0001477449-23-000105 · wk-form4_1701810434.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,117 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000105 · wk-form4_1701810434.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,020 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000105 · wk-form4_1701810434.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 506 | $22.89 | $11,584.36 |
DisclosureSEC source: 0001477449-23-000045 · wk-form4_1694031486.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,222 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000045 · wk-form4_1694031486.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,424 Underlying: Common Stock · 1,403 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,403 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000045 · wk-form4_1694031486.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 16:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 495 | $24.38 | $12,068.60 |
DisclosureSEC source: 0001415889-23-009206 · form4-06052023_080607.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,325 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 16:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009206 · form4-06052023_080607.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,827 Underlying: Common Stock · 1,403 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 16:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,403 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009206 · form4-06052023_080607.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 39,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004414 · form4-03072023_090351.xml · derivative · entry 2 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,063 Underlying: Common Stock · 39,063 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,873 | $25.91 | $74,442.30 |
DisclosureSEC source: 0001415889-23-004414 · form4-03072023_090351.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,417 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 16 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437 Underlying: Common Stock · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F13 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 874 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 15 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874 Underlying: Common Stock · 874 shares Expires not disclosed F10 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. F12 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. F12 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 14 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 13 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,148 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 12 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F7 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,545 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 11 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021 F6 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,218 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · derivative · entry 10 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,422 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 8 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004096 · form4-03032023_090316.xml · nonDerivative · entry 7 Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.